Pricing Log in Create free account

Akanda Corp. (AKAN) vs Apimeds Pharmaceuticals US, Inc. (APUS)

Akanda Corp. and Apimeds Pharmaceuticals US, Inc. are both Drug Manufacturers Specialty & Generic companies. Apimeds Pharmaceuticals US, Inc. is the larger, with a market value of $4.1M against $2.2M — 1.8× the size. Across the 8 metrics below, Akanda Corp. leads on 7 and Apimeds Pharmaceuticals US, Inc. on 1.

Valuation

Metric AKAN APUS Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — n/m 2.08
P/B n/m 0.04 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m n/m 2.87
Earnings yield — (1,394.72%) (15.94%)
Free cash flow yield 0.00% (295.94%) 0.00%

Profitability

Metric AKAN APUS Drug Manufacturers Specialty & Generic median
Gross margin — — 53.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (100.13%) (0.80%)
Return on assets 0.00% (84.20%) (1.67%)
Return on invested capital 0.00% (15.96%) 0.00%

Growth

Metric AKAN APUS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 5.22%
EPS growth (last fiscal year) (139.63%) (205.56%) 42.91%
Revenue growth, 5-year CAGR 161.77% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AKAN APUS Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) 0.08 0.04
Current ratio 0.22 0.51 2.41
Net debt to EBITDA (2.75) 0.38 1.01

Dividend

Metric AKAN APUS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AKAN APUS Drug Manufacturers Specialty & Generic median
Market cap 2.24m 4.12m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack